BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 26.90
+0.30 (1.13%)
At close: May 28, 2026
BioVersys AG Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, BioVersys AG stock has a consensus rating of "Strong Buy" and an average price target of CHF 58.26. The average 1-year stock price forecast is 116.58% higher than the current stock price, while the lowest is CHF 40.00 (+48.70%) and the highest is CHF 71.30 (+165.06%).
Price Target: CHF 58.26 (+116.58%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 17, 2026.
Analyst Ratings
The average analyst rating for BioVersys AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates CHF 40.00 | Buy | Reiterates | CHF 40.00 | +48.70% | Apr 17, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates CHF 70.00 | Buy | Reiterates | CHF 70.00 | +160.22% | Mar 31, 2026 |
| UBS | UBS | Buy Initiates CHF 48.00 | Buy | Initiates | CHF 48.00 | +78.44% | Dec 11, 2025 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.